Skip to content
Screener

eXoZymes, Inc. EXOZ Q4 2025 Annual earnings

Reported March 30, 2026

EPS-$0.32

Next report

Date not yet announced

Financials

Q4 2025

Income statement

See full
Operating income-$2.7M-35.9%
Net income-$2.7M-44.6%
EPS (diluted)-$0.31-24.0%

Balance sheet

See full
Cash & equivalents$3.0M-68.7%
Total debt$1.3M-7.2%
Total equity$3.4M-67.4%
Total assets$6.0M-54.2%

Cash flow

See full
Operating cash flow-$2.0M+65.4%
CapEx$75.0K-64.4%
Free cash flow-$2.0M+65.4%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$91.42M—
Enterprise value$89.67M—

Returns & leverage

See full
Return on equity-132.6%—
Debt / equity0.4×+0.2×
Current ratio2.5×-5.6×

FAQ

When did eXoZymes, Inc. report Q4 2025 earnings?
eXoZymes, Inc. (EXOZ) reported Q4 2025 earnings on March 30, 2026.
What were eXoZymes, Inc.'s Q4 2025 revenue and EPS?
eXoZymes, Inc. reported eps of $-0.32 for Q4 2025.
Where can I find eXoZymes, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-013733) and the 10-K periodic report (0001493152-26-013563) directly on SEC EDGAR. The filing index links above go to sec.gov.